Abstract
IntRoduCtIon
O ptic neuritis (ON) is an inflammatory condition of the optic nerve commonly seen in central nervous system (CNS) demyelinating diseases such as multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) and recently recognized in myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) related diseases. However, these causes may not be identifiable, especially in Asian populations. Several weeks after an ON attack, optic nerve fibers are lost, resulting to the thinning of the retinal nerve fiber and ganglion cell layers. Recent studies reported that the thinning quickly aggravates within the first 3mo from the onset of ON attack and gradually continues until 6mo [1] [2] [3] . Damage to the optic nerve and its fibers can be measured objectively by optical coherence tomography (OCT) as a thickening of the retinal nerve fiber layer (RNFL) around optic nerve head and the ganglion cell-inner plexiform layers (GCIPL) at macula area (ganglion cell complex) [4] [5] . Previous studies reported that ON in NMOSD resulted to a more severe RNFL and ganglion cell layer thinning than in MS, and suggested that OCT might be useful in differentiating NMOSD from MS [6] [7] [8] [9] . However, comparative studies of the OCT in various types of CNS-demyelinating diseases are limited. Moreover, there are now only a limited number of published studies regarding OCT in MOG-IgG-positive patients. The objective of this study was to identify whether any particular OCT parameters or their thinning pattern can be used to distinguish the type of ON.
SubjeCtS and MethodS eligible Patients
This prospective study was conducted at the Department of Ophthalmology, Faculty of Medicine, Siriraj Hospital, Thailand, between January, 2015 and December, 2016. We enrolled patients >18 years of age with a history of acute ON but were without an acute episode for at least the previous 3mo. Diagnosis of ON was based on a history of subacute onset of decreased vision, a relative afferent pupillary defect when unilateral, and gadolinium enhancement of the optic nerve on fat-suppressed magnetic resonance imaging (MRI) at onset. Exclusion criteria were patients with other optic nerve disorders (ischemic optic neuropathy, glaucoma, neuroretinitis, perineuritis, ON related with CNS infection/toxic/malignancy), macula diseases, pathologic myopia with spherical equivalent of the refractive error >6.0 diopters. This study was approved by Siriraj Institutional Review Board and was conducted in accordance with the Declaration of Helsinki for biomedical research. All participants gave their written consent. We categorized patients with CNS demyelinating related ON as the follows. 1) AQP4-IgG+ON was defined as eyes with a history of ON from patients whose blood tested seropositive for aquaporin 4 antibody (AQP4-IgG; diagnosed as NMOSD with AQP4 [10] ). All serum samples were analyzed at Tohoku University to detect AQP4 and MOG antibodies using cellbased assays [11] [12] . 2) MS-ON was defined as eyes with a history of ON from patients who fulfilled the revised 2010
McDonald Criteria for diagnosis of MS [13] . 3) MOG-IgG+ON was defined as eyes with a history of ON from patients that tested seropositive for MOG-IgG. MOG-IgG were measured using a cell-based assay [11] [12] . Serum samples were obtained Figure 1 ). No significant decrease in GCIPL thickness was found in any ON groups after subsequent ON attacks. dISCuSSIon Several previous studies reported NMOSD caused more severe RNFL thinning at 55-83 μm than in MS at 74-95 μm [6, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
Our study demonstrated RNFL thickness in MS-ON were impaired less than in AQP4-IgG+NMOSD-ON, MOGIgG+ON and idiopathic-ON groups. We found the mean RNFL thickness was 65±11 μm in AQP4-IgG+ON, 79±9 μm in MS-ON, 57±13 μm in MOG-IgG+ON, and 68±14 μm in idiopathic-ON. These findings are in accordance with those of the previous reports and add more data to literature on OCT in MOG-IgG+ autoimmunity. Few studies have reported macular GCIPL measurements in previous ON eyes. Our study found that GCIPL thickness from all macular sectors of all ON groups was significantly different and less than those from healthy controls (P<0.001). This may reflect the high sensitivity of GCIPL measurements in distinguishing between previous ON and normal eyes. Differences in macular GCIPL measurements between MS-ON and AQP4-IgG+ON remain debatable. Some studies reported greater GCIPL loss in AQP4-IgG+ON while others reported no difference [8, [22] [23] . We confirmed the smaller loss in MS-ON compared with that in AQP4-IgG+ON. Currently it is debated whether MOG-IgG-associated disorders should be classified as NMOSD or as opticospinal MS, or as a unique disease entity [24] [25] . MOG-IgG have been detected in a proportion of AQP4-IgG negative NMOSD patients [11, [26] [27] [28] .
However, the clinical features, histopathology of lesions, and evidence from immunological studies of MOG-IgG+ patients have been shown to differ from those of AQP4-IgG+ patients [24] [25] [29] [30] [31] . [32] . One study, published in 2017, reported that RNFL was better preserved in eyes of patients with MOG-IgG compared to those with AQP4-IgG [33] . However, a larger study on a Caucasian population reported severe RNFL and GCIPL thinning in MOG-IgG+ON were comparable to AQP4-IgG+ON [34] and in general accord with the findings of our study other than race of patients. Some previous studies observed that MOG-IgG+ON patients have better visual recovery from relapses than AQP4-IgG+ON patients [11] [12] [33] [34] [35] . We found that VA in MOG-IgG+ON was slightly, but not significantly, better than that for AQP4-IgG+ON, whereas the structural change from OCT was comparable. In this study, 7 of 8 MOG-IgG+ON experienced recurrent ON attacks which can result in the significant thinning of RNFL. However, severe thinning can still be observed after classifying it by the number of ON episode, particularly in recurrent ON (Figure 1 ). According to the results, wherein MOG-IgG+ON causes visual impairment and GCIPL thinning (but not RNFL) is comparable to MS-ON, may imply that MOG-IgG+ON preserve macular ganglion cells and central vision, which is in contrast to AQP4-IgG+ON.
According to the correlation between number of episodes of ON and OCT thinning, Ratchford et al [7] estimated a single episode of ON caused a 31 μm decrease in RNFL thickness in patients with NMOSD and a reduction of 10 μm in MS. Moreover, subsequent episodes of ON in the same eye were estimated to each cause an additional loss of 10 μm of RNFL thickness in NMOSD in comparison with a non-significant change in the MS group [7] . Our study demonstrated that after the first episode of ON, average RNFL thickness decreased 33 μm in AQP4-IgG+ON, 13 μm in MS-ON, 19 μm in MOGIgG+ON, and 26 μm in idiopathic-ON when compared with those baselines of non-ON groups. However, after subsequent ON attacks, RNFL thickness in the AQP4-IgG+ON, MOGIgG+ON, and idiopathic-ON groups showed a trend towards further thinning, but each episode of ON associated with an additional loss of <5 μm in RNFL thickness. These are the varying results between our study and Ratchford et al's [7] . We also observed that the cases with history of single ON episode, OCT in MS-ON was significantly better compared with AQP4-IgG+ON than with MOG-IgG+ON. However, in a recurring second or more episodes, OCT findings in MOGIgG+ON were similar to AQP4-IgG+ON and apparently reduced its comparability with MS-ON. Some studies found that temporal quadrant of peripapillary RNFL are preferentially affected in MS-ON, whereas AQP4-IgG+ON affected RNFL in all quadrants especially the superior and inferior [14, [17] [18] 36] . Our study enlisted nearly all types of common inflammatory demyelinating ON and found that superior and inferior RNFL were two best parameters for distinguishing the type of ON (Tables 3, 4) . Long term treatments differ among MS and other demyelinating diseases. Hence any decision on how a patient should be treated with disease-modifying therapies for MS or immunosuppressive agents for other types of ON is very important [34] . Some MS medications can activate attack of NMOSD [37] [38] [39] [40] [41] [42] . Thus, OCT may have an important role in making a treatment decision. Idiopathic-ON group in our study, which may also be referred to as unclear diagnostic group, showed poor visual outcome and thinning of inner retinal structure that is comparable to AQP4-IgG+ON group. These results may not be applicable to patients with Caucasian descent, wherein possibility to develop MS is high [43] . Gonzales in reviewing of this manuscript. authors' contributions: Mekhasingharak N initiated the project, designed the data collection tools, monitored the data collection for the whole trial, wrote the statistical analysis plan, cleaned and analyzed the data, as well as drafted and revised the manuscript. Chirapapaisan N initiated the project, designed the data collection tools, monitored the data collection for the whole trial, revised the manuscript, approved the final manuscript prior to journal submission, and supervised the study. Laowanapiban P initiated the project, designed the data collection tools, and revised the manuscript. Siritho S initiated the project, revised the manuscript, and supervised the study. Satukijchai C, Prayoonwiwat N and Jitprapaikulsan J initiated the project and revised the manuscript. Conflicts of Interest: Mekhasingharak n, None; laowanapiban P, None; Siritho S has received funding for travel and speaker honoraria from Merck Serono, Pacific Healthcare (Thailand), Menarini (Thailand), Biogen Idec, UCB (Thailand) and Novartis; Satukijchai C has received funding for travel from Merck Serono, Biogen Idec, UCB (Thailand) and Novartis; Prayoonwiwat n has received funding for travel and speaker honoraria from Bayer Schering Pharma, Eisai Inc, Pfizer Pharmaceutical Company Limited, Novartis, SanofiAventis; jitprapaikulsan j, None; Chirapapaisan n, None; Siriraj neuroimmunology Research Group, None.
